Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models

In head and neck squamous cell cancer, the human epidermal growth factor receptor 1 (EGFR) is the dominant signaling molecule among all members of the family. So far, cetuximab is the only approved anti-EGFR monoclonal antibody used for the treatment of head and neck squamous cell cancer, but despit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Burley, Thomas A., Da Pieve, Chiara, Martins, Carlos D., Ciobota, Daniela M., Allott, Louis, Oyen, Wim J.G, Harrington, Kevin J., Smith, Graham, Kramer-Marek, Gabriela
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2019
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424230/
https://ncbi.nlm.nih.gov/pubmed/30213849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.216069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados